CarGurus, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CarGurus, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $90.60M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $82.99M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $76.24M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $67.04M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $60.76M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $53.14M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $45.63M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $38.61M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $98.59M | Mar 1, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.09M | Feb 19, 2026 |
| FY2025 | Sep 30, 2025 | $231.65M | Feb 19, 2026 |
| FY2025 | Jun 30, 2025 | $222.00M | Feb 19, 2026 |
| FY2025 | Mar 31, 2025 | $212.24M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $210.24M | Feb 19, 2026 |
| FY2025 | Sep 30, 2024 | $204.55M | Feb 19, 2026 |
| FY2025 | Jun 30, 2024 | $195.85M | Feb 19, 2026 |
| FY2025 | Mar 31, 2024 | $187.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $698.42M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.66B | Feb 20, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $222.59M | Feb 19, 2026 |
| FY2025 | Sep 30, 2025 | $214.71M | Feb 19, 2026 |
| FY2025 | Jun 30, 2025 | $206.32M | Feb 19, 2026 |
| FY2025 | Mar 31, 2025 | $197.89M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $196.09M | Feb 19, 2026 |
| FY2025 | Sep 30, 2024 | $179.47M | Feb 19, 2026 |
| FY2025 | Jun 30, 2024 | $180.58M | Feb 19, 2026 |
| FY2025 | Mar 31, 2024 | $171.57M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $636.61M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $657.55M | Feb 20, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.90M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $20.97M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $36.94M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $84.39M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $109.24M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $77.55M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $13.17M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $10.38M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $6.01M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $12.58M | Feb 14, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $244.45M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $157.15M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $120.33M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $108.48M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $148.27M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $97.76M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $13.64M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $9.70M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $3.55M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $7.44M | Feb 14, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.28M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $139.01M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $136.76M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $123.77M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $106.42M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $85.73M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $69.46M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $47.87M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $22.47M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $11.45M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.28M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $255.49M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $124.53M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $256.11M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $98.29M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $156.74M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $70.12M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $51.72M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $25.69M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $20.00M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.38M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $75.17M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $24.56M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $5.92M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $7.71M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $2.95M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $11.21M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $5.96M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $5.16M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $5.85M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $661.90M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $824.54M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $918.93M | Feb 20, 2025 |
| FY2024 | Dec 31, 2022 | $927.10M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $931.57M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $502.30M | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | $393.62M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $268.29M | Feb 14, 2020 |
| FY2019 | Dec 31, 2017 | $176.59M | Feb 14, 2020 |
| FY2017 | Dec 31, 2016 | $100.33M | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $287.70M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $282.85M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $302.08M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $155.74M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $251.93M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $128.71M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $136.77M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $74.18M | Feb 14, 2020 |
| FY2019 | Dec 31, 2017 | $49.57M | Feb 14, 2020 |
| FY2017 | Dec 31, 2016 | $35.61M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $374.20M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $541.69M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $616.85M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $734.61M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $516.84M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $373.59M | Feb 26, 2024 |
| FY2022 | Dec 31, 2019 | $256.86M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $194.11M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $127.03M | Feb 12, 2021 |
| FY2019 | Dec 31, 2016 | ($67.97M) | Feb 14, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $26.60M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $157.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $157.47M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $158.29M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $29.13M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $15.21M | Feb 12, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.38M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $375.12M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $354.15M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $323.04M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $129.26M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $129.41M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $51.86M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $9.71M | Feb 14, 2020 |
| FY2019 | Dec 31, 2017 | ($58.50M) | Feb 14, 2020 |
| FY2017 | Dec 31, 2016 | ($71.70M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.52M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $304.19M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $291.36M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $469.52M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $231.94M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $190.30M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $59.92M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $34.89M | Feb 14, 2020 |
| FY2019 | Dec 31, 2017 | $87.71M | Feb 14, 2020 |
| FY2017 | Dec 31, 2016 | $29.48M | Mar 1, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 1, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 20, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |